G6PD and G6PD deficiency: AccessBio (New Jersey, USA) has developed a new experimental RDT called CareStartTM G6PD deficiency screening test and its first assessment outside of their laboratories is reported here, by comparing its performance to the gold standard, quantitative spectrophotometric estimation of G6PD enzyme activity [14].